Axona

Axona is a medical food designed to provide an alternative energy source for brain cells that have lost their ability to use glucose due to Alzheimer's disease. It is a product of Accera, a biotechnology company specializing in the development of treatments for neurodegenerative diseases.

Mechanism of Action

Axona works by providing the brain with ketone bodies, an alternative energy source that brain cells can use when they are unable to metabolize glucose effectively. The active ingredient in Axona is caprylic triglyceride, a type of medium-chain triglyceride (MCT) that the liver can convert into ketone bodies.

Clinical Trials

Several clinical trials have been conducted to evaluate the effectiveness of Axona in treating Alzheimer's disease. These trials have shown that Axona can improve cognitive function in some patients with mild to moderate Alzheimer's disease. However, more research is needed to confirm these findings and to determine the long-term effects of Axona treatment.

Side Effects

The most common side effects of Axona are gastrointestinal in nature and include nausea, diarrhea, and flatulence. These side effects are generally mild and can be managed by adjusting the dose of Axona or taking it with food.

Contraindications

Axona should not be used in patients with a history of pancreatitis or other conditions that affect the ability of the pancreas to metabolize fats. It should also not be used in patients with a known hypersensitivity to caprylic triglyceride or any other ingredient in Axona.

See Also

• Alzheimer's disease
• Ketogenic diet
• Medium-chain triglyceride

References

‎